Neola | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

16 results for “Neola”

Trials

View all 11 →

Study to Assess Safety and Performance of Neola®, a Novel Lung Monitoring Device for Neonates

10 participants · First posted Apr 8, 2025

Not yet recruiting

Pivotal Study to Assess Safety and Performance of Neola®, a Novel Lung Monitoring Device for Neonates

22 participants · First posted Jul 11, 2025

Active, not recruiting

To Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of it With Stage III, Unresectable NSCLC With EGFR Mutations

76 participants · First posted Jan 8, 2024

Drugs

NeoEA-1001

Organizations

NEORA INTERNATIONAL PTY LTD

Australia

News

FDA grants Breakthrough Device Designation to Neola for continuous lung monitoring

FDA Grants Breakthrough Device Designation to Neola® for Continuous Lung Monitoring in Preterm Infants

Leclaza Downstages Lung Cancer in 55% of Patients in Preoperative Trial

Page 1 of 2